[Polychemotherapy with platidiam and prospidin in disseminated squamous-cell lung cancer]

The effectiveness of combination chemotherapy with platidiam and prospidin was assessed in 58 patients with squamous-cell lung cancer. Complete or partial remissions were achieved in 48.3% of cases. Toxicity was moderate. The addition of gamma-ray teletherapy after chemotherapy in the total focal dose of 60-70 Gy was followed by an increase in the remission rate (88.9%) and mean survival (from 8.5 +/- 1.3 to 16.0 +/- 3.5 months).